MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells

Carcinogenesis

Volumn 32, Issue 12, 2011, Pages 1832-1839

  Srivastava, Sanjeev K ^a   Bhardwaj, Arun ^a   Singh, Seema ^a   Arora, Sumit ^a   Wang, Bin ^a   Grizzle, William E ^b   Singh, Ajay P ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MICRORNA; MICRORNA 150; MUCIN 4; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER CELL; CANCER INHIBITION; CANCER TISSUE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; HUMANS; MICRORNAS; MUCIN-4; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION;

EID: 81855183857     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr223     Document Type: Article

References (39)

1. Jemal,A. et al. (2010) Cancer statistics, 2010. CA Cancer J. Clin., 60, 277-300.
2. Singh,S. et al. (2010) CXCL12-CXCR4 signalling axis confers gemcita-bine resistance to pancreatic cancer cells: a novel target for therapy. Br. J. Cancer, 103, 1671-1679.
3. Li,D. et al. (2004) Pancreatic cancer. Lancet, 363, 1049-1057.
4. Bardeesy,N. et al. (2002) Pancreatic cancer biology and genetics. Nat. Rev. Cancer, 2, 897-909.
5. Rhim,A.D. et al. (2010) Molecular biology of pancreatic ductal adenocar-cinoma progression: aberrant activation of developmental pathways. Prog. Mol. Biol. Transl. Sci., 97, 41-78.
6. Koorstra,J.B. et al. (2008) Pancreatic carcinogenesis. Pancreatology, 8, 110-125.
7. Mimeault,M. et al. (2005) Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas, 31, 301-316.
8. Chaturvedi,P. et al. (2008) Structure, evolution, and biology of the MUC4 mucin. FASEB J., 22, 966-981.
9. Andrianifahanana,M. et al. (2001) Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin. Cancer Res., 7, 4033-4040.
10. Swartz,M.J. et al. (2002) MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am. J. Clin. Pathol., 117, 791-796.
11. Chaturvedi,P. et al. (2007) MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol. Cancer Res., 5, 309-320.
12. Singh,A.P. et al. (2004) Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res., 64, 622-630.
13. Singh,A.P. et al. (2007) Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Res., 67, 433-436.
14. Carraway,K.L. et al. (2009) Muc4/MUC4 functions and regulation in cancer. Future Oncol., 5, 1631-1640.
15. Bhardwaj,A. et al. (2010) MicroRNA-based cancer therapeutics: big hope from small RNAs. Mol. Cell. Pharmacol., 2, 213-219.
16. Garzon,R. et al. (2009) MicroRNAs in cancer. Annu. Rev. Med., 60, 167-179.
17. Iorio,M.V. et al. (2009) MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol., 27, 5848-5856.
18. Chaturvedi,P. et al. (2008) MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Res., 68, 2065-2070.
19. Chen,C. et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res., 33, e179.
20. Glazov,E.A. et al. (2008) Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals. Mol. Biol. Evol., 25, 939-948.
21. Lee,E.J. et al. (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer, 120, 1046-1054.
22. Szafranska,A.E. et al. (2007) MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adeno-carcinoma. Oncogene, 26, 4442-4452.
23. Wang,M. et al. (2008) miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J. Pathol., 215, 13-20.
24. Watanabe,A. et al. (2011) The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia, 25, 1324-1334.
25. Lin,M. et al. (2011) MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol. Rep., 25, 739-747.
26. Wu,Q. et al. (2010) MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem. Biophys. Res. Commun., 392, 340-345.
27. Xiao,C. et al. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell, 131, 146-159.
28. Zhou,L. et al. (2008) MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript. J. Biol. Chem., 283, 28274-28286.
29. Carraway,K.L. et al. (2002) Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog. Nucleic Acid Res. Mol. Biol., 71, 149-185.
30. Hamada,T. et al. (2011) MUC4 is a novel prognostic factor of oral squamous cell carcinoma. Int. J. Cancer. doi:10.1002/ijc.26187.
31. Hoebler,C. et al. (2006) MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice. Dig. Dis. Sci., 51, 381-389.
32. Ponnusamy,M.P. et al. (2008) MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br. J. Cancer, 99, 520-526.
33. Singh,A.P. et al. (2007) MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene, 26, 30-41.
34. Hollingsworth,M.A. et al. (2004) Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer, 4, 45-60.
35. Chen,C.Z. (2005) MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med., 353, 1768-1771.
36. Calin,G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
37. Sachdeva,M. et al. (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res., 70, 378-387.
38. * inhibits androgen receptor expression in prostate carcinoma cells. Int. J. Cancer, 129, 810-819.
39. Trajkovski,M. et al. (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature, 474, 649-653.